<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[abt associates Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/abt+associates.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to abt associates]]></description>
	<s:counts start="0" returned="4" found="4" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Loyalty and Competitive Advantage: Breakthrough Work in the Area of Customer Loyalty]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=153279]]></link>
		<description><![CDATA[Customer loyalty has become an even more strategic imperative for firms. As the economy shifts and revenues begin to decline, customer retention is an absolute imperative for companies. Customer acquisition is expensive. Declining revenues almost always translate into shrinking budgets and companies are not in the position to mount sizeable...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Wed, 18 May 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/acquisition.html"><![CDATA[Acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/customer+acquisition.html"><![CDATA[Customer Acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/competitive+advantage.html"><![CDATA[Competitive Advantage]]></category>
		<category domain="http://resources.bnet.com/topic/imperative.html"><![CDATA[Imperative]]></category>
		<category domain="http://resources.bnet.com/topic/abt+associates.html"><![CDATA[Abt Associates]]></category>
		<category domain="http://resources.bnet.com/topic/customer+loyalty.html"><![CDATA[Customer Loyalty]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
	</item>
	<item>
		<title><![CDATA[Medicaid and Medicare Drug Pricing: Strategy to Determine Market Prices]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=153281]]></link>
		<description><![CDATA[This report provides background on current Medicaid and Medicare policy and the structure of the pharmaceutical marketplace and of pharmaceutical prices and payments, highlighting implications for the estimation of acquisition costs and for payment policy. Alternative approaches for estimating pharmacies' and physicians' acquisition costs for prescription drugs are then described...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 30 Aug 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/acquisition.html"><![CDATA[Acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/payment.html"><![CDATA[Payment]]></category>
		<category domain="http://resources.bnet.com/topic/medicaid.html"><![CDATA[Medicaid]]></category>
		<category domain="http://resources.bnet.com/topic/medicare.html"><![CDATA[Medicare]]></category>
		<category domain="http://resources.bnet.com/topic/pricing+strategy.html"><![CDATA[Pricing Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/abt+associates.html"><![CDATA[Abt Associates]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
	</item>
	<item>
		<title><![CDATA[Tax Incentives for Long Term Care Insurance: A Microsimulation Analysis]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=167904]]></link>
		<description><![CDATA[The goal of stimulating additional private long-term care coverage is attractive to policy makers because of the potential benefits to the Medicaid program. Medicaid is the most vulnerable component of the current long-term care financing system because it is the largest long-term care insurer and it is partially funded by...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Mon, 31 Dec 2001 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/tax+incentive.html"><![CDATA[Tax Incentive]]></category>
		<category domain="http://resources.bnet.com/topic/tax.html"><![CDATA[Tax]]></category>
		<category domain="http://resources.bnet.com/topic/long-term+care.html"><![CDATA[Long-term Care]]></category>
		<category domain="http://resources.bnet.com/topic/abt+associates.html"><![CDATA[Abt Associates]]></category>
	</item>
	<item>
		<title><![CDATA[The Simple Economics of Voluntary Versus Mandated Drug Benefits for Medicare]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=167905]]></link>
		<description><![CDATA[This paper analyzes voluntary and mandated drug insurance from the perspective of economic theory. It offers a simple graphical analysis that is designed to bring out several features of the market for drug insurance in the presence of adverse selection and the constraint that insurers charge a single premium to...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Tue, 01 May 2001 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/medicare.html"><![CDATA[Medicare]]></category>
		<category domain="http://resources.bnet.com/topic/benefit.html"><![CDATA[Benefit]]></category>
		<category domain="http://resources.bnet.com/topic/abt+associates.html"><![CDATA[Abt Associates]]></category>
		<category domain="http://resources.bnet.com/topic/insurance.html"><![CDATA[Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/financial+planning.html"><![CDATA[Financial Planning]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+insurance.html"><![CDATA[Corporate Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
	</item>
</channel>
</rss>
